Vesugen
Research profile · How we handle evidence
Peptide derived from calf aorta that supports vascular health and tissue regeneration.
Evidence Score
Preclinical signal
Category
Therapeutic area
Standard Dose
Daily
Half-life
Plasma elimination
Route
Subcutaneous
Safety Tier
Limited data
Overview
Vesugen is a short peptide described as a bioregulator in the Khavinson-family set. The idea behind it is organ-focused signaling: it’s marketed for vascular tissue support rather than for quick changes like a conventional blood thinner. Human evidence is limited, so treat this entry as educational research context and as reported effects, not as a proven clinical intervention. People who use peptides in this category often pair Vesugen with Cardiogen for broader cardiovascular-focused stacks, then reassess based on personal tolerance and lab trends.
Mechanism of Action
Vesugen is a short peptide described as a bioregulator in the Khavinson-family set. The idea behind it is organ-focused signaling: it’s marketed for vascular tissue support rather than for quick changes like a conventional blood thinner. Human evidence is limited, so treat this entry as educational research context and as reported effects, not as a proven clinical intervention. People who use peptides in this category often pair Vesugen with Cardiogen for broader cardiovascular-focused stacks, then reassess based on personal tolerance and lab trends.
pH & Mixing
Peptides reconstituted at very different pH levels can destabilize when combined in the same syringe, which lowers how much of the peptide your body actually absorbs. If you're unsure whether two peptides are close enough in pH, reconstitute and inject them separately.
A dedicated compatibility check between two specific peptides is coming to the Compare tool. This section covers this peptide's pH only.
Benefits
- Vascular support
- Cardiovascular health
- Tissue regeneration
- Blood vessel health
Side Effects
- Reported as generally well-tolerated in limited user reports
- Human side-effect data is not well-established
Contraindications
No entries listed.
Structure & Sequence
Verified structure
Vesugen
Sequence illustration backed by PubChem match.
- Amino Acid Sequence
- Lys-Glu-Asp (KED)
- Molecular Weight
- 390.39 Da
- Chemical Formula
- C15H26N4O8
- CAS Number
- 204271-66-9
- Reconstituted pH
- 4.2
- InChIKey
- LLSUNJYOSCOOEB-GUBZILKMSA-N
Stack & Route Context
Stacks with
- Cardiogen
- Thymosin Beta-4
Administration
Subcutaneous
Research Status
Research peptide for vascular health
Approval Status
Preclinical
Sports Legal
Permitted
References
- 1View source
PubChem: Vesugen
This profile summarizes research literature for education only. It is not medical advice, and it does not diagnose, treat, or recommend a dose. Consult a qualified professional before changing a protocol.